Status:
Concluded with an LOI
Manufacturer:
Marcan Pharmaceuticals Inc.
Indication:
Wilson's Disease
Last updated March 25, 2022
Status:
Concluded with an LOI
Manufacturer:
Organon Canada Inc.
Indication:
Metastatic Colorectal Cancer (mCRC); Locally Advanced, Metastatic or Recurrent Non-Small Cell Lung Cancer (NSCLC); Platinum-Sensitive Recurrent Epithelial Ovarian, Fallopian Tube and Primary Peritoneal Cancer; Platinum-Resistant Recurrent Epithelial Ovarian, Fallopian Tube and Primary Peritoneal Cancer; and Malignant Glioma (WHO Grade IV) - Glioblastoma
Last updated March 16, 2022
Status:
Concluded with an LOI
Manufacturer:
Janssen Inc.
Indication:
Light chain amyloidosis (AL), newly diagnosed in adult patients (in combination with bortezomib, cyclophosphamide, and dexamethasone)
Last updated March 11, 2022
Status:
Concluded without agreement
Manufacturer:
Celltrion Healthcare Canada Ltd.
Indication:
Rheumatoid Arthritis
Last updated March 10, 2022
Insulin pumps and pump supplies (Insulin pumps and pump supplies)
Status:
Concluded with an LOI
Manufacturer:
Ypsomed Canada Inc.
Indication:
Diabetes Mellitus, Type 1 & 2
Last updated March 8, 2022
Insulin pumps and pump supplies (Insulin pumps and pump supplies)
Status:
Concluded with an LOI
Manufacturer:
Medtronic Canada
Indication:
Diabetes Mellitus, Type 1 & 2
Last updated March 8, 2022
Status:
Concluded with an LOI
Manufacturer:
Jamp Pharma Corporation
Indication:
Rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, hidradenitis suppurativa, plaque psoriasis, uveitis
Last updated March 3, 2022
Status:
Concluded with an LOI
Manufacturer:
Novartis Pharmaceuticals Canada Inc.
Indication:
Multiple Sclerosis, Relapsing-Remitting
Last updated March 2, 2022
Status:
Concluded with an LOI
Manufacturer:
Celltrion Healthcare Canada Ltd.
Indication:
Rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, hidradenitis suppurativa, plaque psoriasis, uveitis
Last updated March 1, 2022
Status:
Concluded with an LOI
Manufacturer:
Pfizer Canada ULC
Indication:
Rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, hidradenitis suppurativa, plaque psoriasis, uveitis
Last updated February 28, 2022